Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Patent 8252795 was granted and assigned to Bristol-Myers Squibb on August, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8252795

Patent Inventor Names

Yufen Zhao0

Andrew James Nation0

Ashvinikumar V. Gavai0

Brian E. Fink0

Libing Chen0

Liqi He0

Litai H. Zhang0

Soong-Hoon Kim0

Date of Patent

August 28, 2012

Patent Application Number

12575589

Date Filed

October 8, 2009

Patent Citations Received

‌

US Patent 11999742 Substituted pyrrolo[1,2-b]pyridazines as anthelmintics

‌

US Patent 11964977 Anthelmintic heterocyclic compounds

Patent Primary Examiner

‌

Paul V Ward

Patent abstract

The invention provides compounds of Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API